Case Study: Capacity Expansion and Conversion to Single-Use BioProcessing at an Existing cGMP CDMO Facility

Case Study: Capacity Expansion and Conversion to Single-Use BioProcessing at an Existing cGMP CDMO Facility

04/17/2018, 3:30 PM - 4:15 PM

Technical Conference Stage 1, Booth 1076, Exhibit Hall

Language:
English

With growing demand in the biologics CDMO market, Merck KGaA (Darmstadt, Germany) elected to expand capacity at its existing cGMP biomanufacturing facility in Martillac, France. In so doing, the decision was also made to convert from previously-installed fixed/stainless steel equipment to single-use technologies wherever feasible. From design through implementation and experiences thereafter, this case study serves to illustrate a real-world example of a situation that many growing biopharma companies are considering today.

Contributors

  • Shawn Smith

    Speaker

    Associate Director, Marketing E2E Americas

    MilliporeSigma

Type of Session

  1. Type of Session
    Session

Learning Objectives

  1. Learning Objectives 1. cost-in-use benefits of single-use technologies in bioprocessing 2. considerations around deciding 'how' to expand capacity: new build/greenfield, conversion of existing un-classified space, adding modular build-outs onto an existing facility 3. lessons learned in converting from pre-existing fixed/stainless steel equipment to single-use alternatives

Categories

  1. Track
    Optimizing Facilities through Innovation & Technologies

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.